ERYTHROCYTE INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR EVALUATION IN NORMAL SUBJECTS, ACROMEGALICS, AND GROWTH HORMONE-DEFICIENT AND INSULIN-DEPENDENT DIABETIC CHILDREN
W. Elandere et al., ERYTHROCYTE INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR EVALUATION IN NORMAL SUBJECTS, ACROMEGALICS, AND GROWTH HORMONE-DEFICIENT AND INSULIN-DEPENDENT DIABETIC CHILDREN, Metabolism, clinical and experimental, 44(7), 1995, pp. 923-928
Insulin-like growth factor-I (IGF-I) receptors are characterized in se
veral animal and human tissues. IGF-I receptor studies performed in er
ythrocytes to assess IGF-I receptor status at target-cell tissues are
potentially useful for clinical studies, since tissue biopsies or cult
ures are not required. However, validation of results is challenged by
some investigators on the basis of discrepancies described in compara
tive studies with other cell types, probably related to populations of
different cell ages affecting binding to red blood cells (RBCs). By c
orrecting cell age for creatine, we studied IGF-I receptor status in 2
4 normal subjects (11 adults and 13 children, eight prepubertal and fi
ve pubertal) and 33 patients with pathologic conditions (five adult ac
romegalics, six children with pituitary dwarfism, and 22 type I diabet
ic children, 15 prepubertal and seven pubertal). Acromegalic patients
with higher plasma IGF-I and insulin levels presented lower IGF-I spec
ific binding ([B-o] mean +/- SEM, 6.1% +/- 0.8%) and affinity ([ED(50)
] 28.5 +/- 2.2 ng/mL) than normal adults (B-o, 10.9% +/- 0.7%; ED(50),
16.4 +/- 0.9 ng/mL; P < .001), and growth hormone (GH)-deficient chil
dren showed higher IGF-I binding (24.6% +/- 1.7%, P < .001) without si
gnificant affinity alterations than normal prepubertal children (B-o,
14.7% +/- 1.0%). Both prepubertal and pubertal type I diabetic childre
n with higher GH levels presented decreased IGF-I binding (11.4% +/- 0
.9% for prepubertal, P < .05; 10.0% +/- 1.1% for pubertal, P < .05) to
RBC receptors in comparison to the respective control group (14.7% +/
- 10% and 14.9% +/- 1.3%, prepubertal and pubertal, respectively). Whe
reas in pubertal diabetics mean IGF-I basal levels were significantly
reduced as compared with the respective controls, no difference was ob
served in mean IGF-I basal levels in normal and diabetic prepubertal c
hildren. Copyright (C) 1995 by W.B. Saunders Company